Journal of Alzheimers Disease & Parkinsonism
Open Access

Maria Azzopardi

Human Genetics Group, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, UK

Biography

Dr Maria Azzopardi Skilled in culturing bacterial, yeast and mammalian cells. She is Experienced in performing several techniques related to microbiology and molecular biology, including but not limited to, DNA and RNA extraction, polymerase chain reaction (PCR) and reverse transcription quantitative PCR (RT-qPCR), genotyping, cloning, sequencing and flow-cytometry. She had Successfully defended her research work carried out in part fulfillment for the degree of Doctor of Philosophy (PhD), which focused on aspirin's chemopreventive properties, at the University of Malta (Centre for Molecular Medicine and Biobanking and Department of Physiology and Biochemistry).

Publications

Investigating Splicing Variants Uncovered by Next-Generation Sequencing the Alzheimer's Disease Candidate Genes, CLU, PICALM, CR1, ABCA7, BIN1, the MS4A Locus, CD2AP, EPHA1 and CD33

Late onset Alzheimer’s disease (LOAD), the most common cause of late onset dementia, has a strong genetic component. To date, 21 disease-risk loci have been identified through genome wide association studies (GWAS). However, the causative functional variant(s) within these loci are yet to be discovered. This study aimed to identify potential ... Read More»

Naomi Clement, Anne Braae, James Turton, Jenny Lord, Tamar Guetta-Baranes, Christopher Medway, Keeley J Brookes, Imelda Barber, Tulsi Patel, Lucy Milla, Maria Azzopardi, James Lowe, David Mann, Stuart Pickering-Brown, Noor Kalsheker, Peter Passmore, Sally Chappell, Kevin Morgan and Alzheimer's Research UK (ARUK) Consortium

Research Article: J Alzheimers Dis Parkinsonism 2016, 6:276

DOI: 10.4172/2161-0460.1000276

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article